ArticleJournal of oncology2022

CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR-485-5p and to Target PAK1.

Yeting Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.